Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 11, 2023
January 31, 2025
2aa5412b-2ce3-4c75-b71e-e133b6e6afe5
Related Documents
Blood Pressure and Pulse Donor Eligibility Requirements – Compliance Policy: Guidance for Industry
Guidance DocumentJuly 17, 2024Center for Biologics Evaluation and Research
Long Term Follow-up After Administration of Human Gene Therapy Products: Guidance for Industry
Guidance DocumentJanuary 28, 2020Center for Biologics Evaluation and Research
Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products: Guidance for Industry
Guidance DocumentAugust 1, 2016Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox